Randox News

Randox Polo 2014: Round-Up

Randox Polo 2014: Round-UpThe start of September once again saw Randox host its annual polo event in Perth, Scotland. The two day affair was a whirlwind of scientific sessions, lavish dinners and of course the main attraction, the anticipated Polo competition, with England fighting it out to be the 2014 winners! Below we have given you a quick summary of two of the scientific sessions:

Adiponectin- an Emerging Risk Factor for Type II Diabetes

The seminar series at the annual Randox Polo 2014 Event included a variety of topics including titles such as “Adiponectin – an emerging risk factor of diabetes” and “The Importance of Measuring Aspirin Resistance”.

Dr. Pauline Armstrong , head of Global Regulatory Compliance at Randox Laboratories presented on the topic of Adiponectin and the emergence of this biomarker as a risk factor for diabetes.  The current tools for risk assessment predominantly include glucose monitoring, oral glucose tolerance test, glycated haemoglobin (HbA1c) and body mass index.  However, these methods only confirm the symptoms as they are used as a short term review of the potential of developing type 2 diabetes (T2D) or diagnosing and monitoring pre-diabetes.   It turns our attention to testing for the risk of developing T2D.  As a key biomarker, Adiponectin has been identified as an important player in monitoring the risk of developing T2D.

T2D remains a cause for concern as it is continuously rising in prevalence in Europe with a 22% increase over 20 years.  Relying on the current diagnostic tools will not lessen the impact of the disease.  Therefore other markers which can be utilised to prevent those at risk from developing the disease is key.  There is evidence which suggests that Adiponectin is the significant marker of importance in monitoring the risk of developing T2D.

Randox supply adiponectin for use on our dedicated clinical chemistry analysers as well as numerous other manufacturer models. Alternatively our Metabolic Syndrome Array II measure adiponectic as well as Cystatin C and C-Reactive Protein allowing for multiplex analysis. For more information see Metabolic and Nutrition Research Brochure for specific test info.

The Importance of Aspirin Resistance

Professor Paul Ames from the William Harvey Research Institute at Queen Mary University London delivered his talk on “the importance of aspirin resistance” with the effect aspirin has on the thromboxane metabolites in the cyclo-oxygenase pathway.

A conclusion drawn from this interesting talk was that poor response to aspirin that is associated with an increased risk for cardiovascular disease.  Thus it has highlighted the importance of effectively assessing aspirin resistance in order to establish individuals who may be at risk.  Utilising 11dhTxB2 as a measurement evaluates the direct effect of ASA and allows a non-invasive method for aspirin resistance monitoring.

Dr Paul Ames on the Randox TxB Cardio assay

We would like to thank the Randox events team for putting on a thoroughly enjoyable weekend which had the perfect mix of science and pleasure, as well as all our customers that joined us and made it truly unforgettable. We hope to see you all again next year.

For more information please read the respective Adiponectin or TxBCardio assay’s pages on www.randox.com alternatively e-mail us at research@randox.com

Leave a Reply

Your email address will not be published. Required fields are marked *